Integer Holdings Corporation (NYSE:ITGR) Receives Average Rating of “Moderate Buy” from Brokerages

Shares of Integer Holdings Corporation (NYSE:ITGR) have been assigned an average rating of “Moderate Buy” from the thirteen research firms that are presently covering the stock, MarketBeat reports. Seven equities research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company. The average 1-year price objective among brokers that have updated their coverage on the stock in the last year is $97.00.

A number of equities analysts recently commented on ITGR shares. Citigroup increased their price objective on Integer from $92.00 to $96.00 and gave the stock a “neutral” rating in a report on Wednesday, July 8th. Freedom Capital upgraded shares of Integer to a “strong-buy” rating in a research note on Wednesday. Piper Sandler reissued an “overweight” rating and issued a $97.00 target price (up from $87.00) on shares of Integer in a research report on Friday, May 1st. Truist Financial increased their price target on shares of Integer from $97.00 to $110.00 and gave the stock a “buy” rating in a research note on Thursday, July 16th. Finally, Weiss Ratings restated a “hold (c)” rating on shares of Integer in a report on Thursday, June 18th.

Integer Stock Performance

Shares of NYSE ITGR opened at $98.61 on Friday. The business’s 50-day moving average price is $92.47 and its two-hundred day moving average price is $88.16. The company has a debt-to-equity ratio of 0.77, a current ratio of 3.75 and a quick ratio of 2.38. Integer has a one year low of $62.00 and a one year high of $111.99. The company has a market capitalization of $3.35 billion, a P/E ratio of 24.59, a price-to-earnings-growth ratio of 2.32 and a beta of 0.64.

Integer (NYSE:ITGR) last issued its earnings results on Thursday, April 30th. The medical equipment provider reported $1.20 earnings per share for the quarter, missing the consensus estimate of $1.21 by ($0.01). Integer had a return on equity of 12.83% and a net margin of 7.64%.The firm had revenue of $439.58 million during the quarter, compared to analyst estimates of $426.48 million. During the same period in the previous year, the company earned $1.31 earnings per share. The business’s revenue for the quarter was up .5% on a year-over-year basis. Integer has set its FY 2026 guidance at 5.830-6.400 EPS. Analysts anticipate that Integer will post 6.04 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Integer

Institutional investors have recently bought and sold shares of the stock. EverSource Wealth Advisors LLC lifted its position in shares of Integer by 48.1% in the first quarter. EverSource Wealth Advisors LLC now owns 360 shares of the medical equipment provider’s stock worth $32,000 after buying an additional 117 shares during the last quarter. Salomon & Ludwin LLC boosted its stake in shares of Integer by 46.8% during the 4th quarter. Salomon & Ludwin LLC now owns 370 shares of the medical equipment provider’s stock worth $29,000 after acquiring an additional 118 shares in the last quarter. Harbor Investment Advisory LLC acquired a new position in shares of Integer during the 2nd quarter valued at about $42,000. TD Private Client Wealth LLC increased its holdings in shares of Integer by 1,037.5% during the 4th quarter. TD Private Client Wealth LLC now owns 455 shares of the medical equipment provider’s stock valued at $36,000 after acquiring an additional 415 shares during the last quarter. Finally, Parkside Financial Bank & Trust raised its stake in shares of Integer by 135.5% in the 4th quarter. Parkside Financial Bank & Trust now owns 464 shares of the medical equipment provider’s stock valued at $36,000 after acquiring an additional 267 shares in the last quarter. 99.29% of the stock is currently owned by institutional investors.

Integer Company Profile

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.